{
    "clinical_study": {
        "@rank": "139482", 
        "arm_group": {
            "arm_group_label": "capsule endoscopies", 
            "arm_group_type": "Active Comparator", 
            "description": "Comparative randomised study Patients are scheduled to have two capsule endoscopies within 2 to 14 days from each other using two different capsule endoscopies the Pillcam SB2 (Given Imaging Israel) and the Capsocam (Capsovision Saratoga United States) The order in which the devices are administered is randomly allocated"
        }, 
        "brief_summary": {
            "textblock": "Comparative, randomized study patients are scheduled to have two capsule endoscopies within\n      2 to 14 days from each other using two different endoscopies the Pillcam SB2 (Given Imaging,\n      Israel) and the Capsocam (Capso Vision Saratoga United States) The order in which the\n      devices are administered is randomly allocated."
        }, 
        "brief_title": "Prospective Comparison of the Diagnostic Yield of Small Bowel Pillcam SB2 and Capsocam Capsule", 
        "completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Anemia", 
            "Gastrointestinal Bleedings", 
            "M\u00e9l\u00e9na", 
            "Angiodysplasia", 
            "Polyps"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anemia", 
                "Gastrointestinal Hemorrhage", 
                "Hemorrhage", 
                "Melena", 
                "Angiodysplasia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Objectives\n\n      Main objective\n\n      To compare the diagnostic yield of both capsules in the same patients with a satisfying\n      concordance coefficient k>0,6\n\n      Secondary objectives\n\n      To compare the sensitivity and specificity of both capsule readings To copmpare the\n      sensitivity and specificity for specific lesions classified in terms of relevance P0 P1 P2\n      To check the tecnical fiability (incidence of technical issues To check the feasibility To\n      evaluate the rate of complete small bowel examination, the small bowel transit time the\n      capsule reading time"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  over 18 years old\n\n          -  obscure digestive bleeding justifying capsule endoscopy\n\n          -  complete endoscopic work up including colonoscopy with ileoscopy and gastroscopy with\n             aneathesia or sedation\n\n          -  absence of concomittent ongoing study\n\n          -  absence of occlusive symptoms of suspected Crohn's disease nor of previous small\n             bowel radiotherapy\n\n          -  filled inform consent\n\n          -  no implanted pace maker\n\n          -  patient being affiliated to the CPAM\n\n        Exclusion Criteria:\n\n          -  under 18 years old\n\n          -  oral iron within 8 days before capsule endoscopy\n\n          -  gastroparesis\n\n          -  pacemaker\n\n          -  swallowing troubles\n\n          -  presence of oclusive symptoms suspected Crohn's disease nor of previous small bowel\n             radiotherapy\n\n          -  pregnancy or risk of pregnancy without efficient oral contraception\n\n          -  absence of written informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "73", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01820182", 
            "org_study_id": "2010-023341-29"
        }, 
        "intervention": {
            "arm_group_label": "capsule endoscopies", 
            "description": "Patients inclusion following inclusion criterias Randomization of capsule ingestion order Videocapsule recording by the two capsules Reading of the two capsules films in randomized order by two different readers in each center Reviewing of discordant capsule films by an expert panel", 
            "intervention_name": "capsule endoscopies", 
            "intervention_type": "Device", 
            "other_name": [
                "Pillcam SB2", 
                "Capsocam"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 28, 2013", 
        "number_of_arms": "1", 
        "official_title": "Prospective Comparison of the Diagnostic Yield of Small Bowel Pillcam SB2 and Capsocam Capsule in Patients With Obscure Digestive Bleedings", 
        "overall_official": {
            "last_name": "Saurin JS Jean Christophe, Msd", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Reading of the two capsules film is randomized order by two different readers in each center", 
            "measure": "number of discordant films between the two capsules with two different readers", 
            "safety_issue": "Yes", 
            "time_frame": "14 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01820182"
        }, 
        "responsible_party": {
            "investigator_affiliation": "H\u00f4pital Edouard Herriot", 
            "investigator_full_name": "Jean Christophe Saurin", 
            "investigator_title": "Proffessor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "H\u00f4pital Edouard Herriot", 
        "sponsors": {
            "collaborator": {
                "agency": "Capso Vision, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "H\u00f4pital Edouard Herriot", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2010"
    }
}